Cargando…
Targeting the Gut Mucosal Immune System Using Nanomaterials
The gastrointestinal (GI) tract is one the biggest mucosal surface in the body and one of the primary targets for the delivery of therapeutics, including immunotherapies. GI diseases, including, e.g., inflammatory bowel disease and intestinal infections such as cholera, pose a significant public hea...
Autores principales: | McCright, Jacob, Ramirez, Ann, Amosu, Mayowa, Sinha, Arnav, Bogseth, Amanda, Maisel, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619927/ https://www.ncbi.nlm.nih.gov/pubmed/34834170 http://dx.doi.org/10.3390/pharmaceutics13111755 |
Ejemplares similares
-
Targeting Lymphatics for Nanoparticle Drug Delivery
por: McCright, Jacob, et al.
Publicado: (2022) -
Inhaled CpG increases survival and synergizes with checkpoint inhibition in lymphangioleiomyomatosis
por: Amosu, Mayowa M, et al.
Publicado: (2023) -
Notch Signaling Regulates Bile Duct Morphogenesis in Mice
por: Lozier, Julie, et al.
Publicado: (2008) -
Efficient burdens decrease nonmedical exemption rates: A cross-county comparison of Michigan’s vaccination waiver education efforts
por: Navin, Mark C., et al.
Publicado: (2020) -
Growth arrest of PPP2R5C and PPP2R5D double knockout mice indicates a genetic interaction and conserved function for these PP2A B subunits
por: Dyson, Jade J., et al.
Publicado: (2021)